Healthcare operations

Fangzhou has launched Novo Nordisk’s once-weekly basal insulin and GLP-1 therapy in China, marking a significant step in diabetes treatment availability.

• leftbrainmarketing Team
• 20. July 2026

Guidance on how first-time mothers can effectively utilize daily postpartum check-ins during the first two weeks after discharge to improve recovery and safety.

• Thorsten Meyer
• 19. July 2026

4DMT announces favorable 2-year data from its PRISM Phase 2b trial targeting wet AMD, showing promising efficacy and safety outcomes.

• leftbrainmarketing Team
• 19. July 2026

Lynk Pharmaceuticals has finished enrolling patients in its Phase III clinical trial for Zemprocitinib targeting ankylosing spondylitis, marking a key milestone.

• leftbrainmarketing Team
• 15. July 2026

A new digital tool aims to identify perimenopausal symptoms early in women aged 40-58, enabling timely care and reducing health and work disruptions.

• Thorsten Meyer
• 7. July 2026

A new retirement care planning tool is being tested to help adult children coordinate care and finances for aging parents amid rising costs and complexity.

• Thorsten Meyer
• 4. July 2026

Pedigree® has voluntarily recalled two lots of its Can High Protein Chopped Chicken & Duck Flavor due to potential foreign material contamination.

• leftbrainmarketing Team
• 3. July 2026

Xeris Biopharma is experiencing a surge in worldwide media coverage, with 23 mentions this week, indicating increased interest in the company and its developments.

• leftbrainmarketing Team
• 3. July 2026

Partner Therapeutics announced the publication of the eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma, detailed in the Journal of Clinical Oncology.

• leftbrainmarketing Team
• 2. July 2026

Small clinics are set to test an AI-powered compliance brief generator designed to streamline regulatory updates and operational workflows.

• Thorsten Meyer
• 2. July 2026